Skip to main content
All lobbying filings

RARE DISEASE COMPANY COALITION

Lobbying for RARE DISEASE COMPANY COALITION · Healthcare

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $70,000.00 expenses · posted Jan 20, 2026

Official filing document

 Bills named in this filing 1
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
 Lobbying activity 2
Trade (domestic/foreign)

BIS-2025-0022 - Rare Disease Exemption for Pharmaceutical Tariffs CMS-5545-P - Rare Disease Exemption from GLOBE Model CMS-5546-P - Rare Disease Exemption from GUARD Model

Pharmacy

HR 1262 - Give Kids a Chance Act of 2025 S 932 - Give Kids a Chance Act of 2025 Rare Disease Exemption for Most Favored Nation Pricing Proposals

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem